Welcome to our dedicated page for Altria Group SEC filings (Ticker: MO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Litigation reserves, FDA rulings, and excise-tax tables make Altria Group’s disclosures some of the most intricate in consumer staples. Finding how much Marlboro drives revenue or how IQOS licensing affects margins inside a 300-page filing is time-consuming. Our platform delivers the Altria Group annual report 10-K simplified and turns dense sections on health contingencies into clear takeaways so you can focus on what moves the dividend.
With AI-powered summaries, Stock Titan converts every Altria Group quarterly earnings report 10-Q filing into plain-English insights, flags shifts in shipment volumes, and alerts you the moment an Altria Group 8-K material events explained hits EDGAR. If you’ve ever searched for “Altria Group SEC filings explained simply” or wondered about “understanding Altria Group SEC documents with AI,” the answer is here. Our real-time feed pairs red-lined changes, financial ratios, and narrative commentary, delivering Altria Group earnings report filing analysis before the market reacts.
Below is what professionals monitor on our page:
- Altria Group insider trading Form 4 transactions and Altria Group Form 4 insider transactions real-time
- Altria Group proxy statement executive compensation details by business segment
- Altria Group executive stock transactions Form 4 patterns ahead of dividend announcements
- Regulatory alerts with Altria Group 8-K material events explained in minutes
No more wading through PDFs—understanding Altria Group SEC documents with AI is now a click away.
Altria Group (MO) filed its Q3 2025 report, showing resilient profitability and cash generation amid portfolio shifts. For the nine months, net revenues were $17.433 billion versus $18.044 billion last year, while operating income was $8.248 billion. Net earnings were $5.830 billion and EPS was $3.45; Q3 EPS was $1.41.
Cash from operations reached $6.019 billion, supporting shareholder returns. The Board raised the quarterly dividend by 3.9% to $1.06 per share, and expanded the 2025 repurchase program to $2.0 billion through December 31, 2026. Year-to-date, the company repurchased 12.3 million shares for $712 million at an average price of $58.08.
Altria recorded a non-cash $873 million goodwill impairment in Q1 tied to the e‑vapor reporting unit following ITC orders affecting NJOY ACE. Smokeable products delivered $8.341 billion in OCI for the nine months, and oral tobacco products generated $1.390 billion. The ABI equity stake had a $9.5 billion fair value versus an $8.1 billion carrying amount as of September 30, 2025. Shares outstanding were 1,678,671,552 as of October 22, 2025.
Altria Group, Inc. expanded its share repurchase program to
Altria also furnished a press release announcing financial results for the quarter ended
Heather A. Newman, Senior Vice President, Chief Strategy & Growth Officer at Altria Group, Inc. (MO), reported a routine insider transaction. On 08/21/2025 she disposed of 10,331 shares of Altria common stock at a price of $67.58 per share; the filing states these shares were withheld to satisfy taxes upon the vesting of Restricted Stock Units. Following the transaction she beneficially owns 120,667 shares in total, which includes 49,755 Restricted Stock Units. Separately, she holds 5,315 shares indirectly in the Altria Deferred Profit-Sharing Plan.
Charles N. Whitaker, SVP and Chief HR Officer & CCO of Altria Group, Inc. (MO), reported a withholding of 10,331 common shares on 08/21/2025 to satisfy taxes on the vesting of restricted stock units. The shares were valued at $67.58 each based on the 08/20/2025 closing price. After this disposition, Whitaker beneficially owns 177,296 shares in total, which includes 44,405 restricted stock units still outstanding. Separately, 983 shares are held indirectly in the Altria Deferred Profit-Sharing Plan. The Form 4 was signed on 08/25/2025.
Salvatore Mancuso, EVP & CFO of Altria Group, Inc. (MO), reported a transaction dated 08/21/2025 in which 15,496 shares of common stock were disposed of at a price of $67.58 per share. The filing states these shares were withheld to satisfy taxes on the vesting of restricted stock units. After the transaction, Mancuso beneficially owned 255,118 shares in total, which includes 83,537 restricted stock units. The filing also reports 5,559 shares held indirectly in the Altria Deferred Profit-Sharing Plan. The form is signed and dated 08/25/2025.
Altria Group (MO) Q2-25 10-Q highlights
For the six months ended 6/30/25, net revenues fell 3.6% YoY to $11.36 bn while net earnings declined 41.8% to $3.46 bn (EPS $2.04 vs $3.41). The prior-year period included a $2.7 bn gain from the sale of IQOS U.S. rights. Ex-gain, operating trends were steadier: gross profit up 2.1% to $7.10 bn; operating income down 3.6% to $5.02 bn after a $873 m non-cash goodwill impairment tied to the e-vapor unit.
Segment OCI: Smokeable products rose 2.9% to $5.40 bn; oral tobacco surged 75% to $0.93 bn, offset by a $1.12 bn loss in “All Other” (e-vapor, Horizon, etc.).
Cash & leverage: Operating cash flow increased to $2.93 bn (vs $2.80 bn), but cash & equivalents dropped to $1.29 bn from $3.13 bn at 12/31/24 following $600 m of share buybacks and $1.61 bn debt repayment. Long-term debt stands at $23.65 bn; book equity remains negative at $(3.21) bn.
Capital returns: A new $1 bn repurchase program was authorized in Jan-25; $0.6 bn completed, $0.4 bn remains. Dividends declared YTD totaled $3.45 bn ($2.04 / share).
Key events: • ITC exclusion order removed NJOY ACE from U.S. market, triggering the goodwill write-down. • No new share restrictions on subsidiaries’ dividend capacity. • Contingent consideration for NJOY flavor PMT approvals increased by $25 m to $45 m.
Liquidity appears sufficient with $2.6 bn unused under an October-2028 revolving credit facility, but ongoing litigation and regulatory actions remain contingencies.
FAQ
What is the current stock price of Altria Group (MO)?
What is the market cap of Altria Group (MO)?
